Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...

The following is a summary of "Lipid Metabolic Reprograming: the Unsung Hero in Breast Cancer Progression and Tumor ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

This study shows that engineered E. coli Nissle 1917 producing indole-3-acetic acid (IAA), an AhR agonist, modulate the tumor ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new ...